PET studies of d-methamphetamine pharmacokinetics in primates: comparison with l-methamphetamine and ( --)-cocaine
- PMID: 17873134
- PMCID: PMC2732342
- DOI: 10.2967/jnumed.107.040279
PET studies of d-methamphetamine pharmacokinetics in primates: comparison with l-methamphetamine and ( --)-cocaine
Abstract
The methamphetamine molecule has a chiral center and exists as 2 enantiomers, d-methamphetamine (the more active enantiomer) and l-methamphetamine (the less active enantiomer). d-Methamphetamine is associated with more intense stimulant effects and higher abuse liability. The objective of this study was to measure the pharmacokinetics of d-methamphetamine for comparison with both l-methamphetamine and (-)-cocaine in the baboon brain and peripheral organs and to assess the saturability and pharmacologic specificity of binding.
Methods: d- and l-methamphetamine and (-)-cocaine were labeled with (11)C via alkylation of the norprecursors with (11)C-methyl iodide using literature methods. Six different baboons were studied in 11 PET sessions at which 2 radiotracer injections were administered 2-3 h apart to determine the distribution and kinetics of (11)C-d-methamphetamine in brain and peripheral organs. Saturability and pharmacologic specificity were assessed using pretreatment with d-methamphetamine, methylphenidate, and tetrabenazine. (11)C-d-Methamphetamine pharmacokinetics were compared with (11)C-l-methamphetamine and (11)C-(-)-cocaine in both brain and peripheral organs in the same animal.
Results: (11)C-d- and l-methamphetamine both showed high uptake and widespread distribution in the brain. Pharmacokinetics did not differ between enantiomers, and the cerebellum peaked earlier and cleared more quickly than the striatum for both. (11)C-d-Methamphetamine distribution volume ratio was not substantially affected by pretreatment with methamphetamine, methylphenidate, or tetrabenazine. Both enantiomers showed rapid, high uptake and clearance in the heart and lungs and slower uptake and clearance in the liver and kidneys. A comparison of (11)C-d-methamphetamine and (11)C-(-)-cocaine showed that (11)C-d-methamphetamine peaked later in the brain than did (11)C-(-)-cocaine and cleared more slowly. The 2 drugs showed similar behavior in all peripheral organs examined except the kidneys and pancreas, which showed higher uptake for (11)C-d-methamphetamine.
Conclusion: Brain pharmacokinetics did not differ between d-and l-methamphetamine and thus cannot account for the more intense stimulant effects of d-methamphetamine. Lack of pharmacologic blockade by methamphetamine indicates that the PET image represents nonspecific binding, though the fact that methamphetamine is both a transporter substrate and an inhibitor may also play a role. A comparison of (11)C-d-methamphetamine and (11)C-(-)-cocaine in the same animal showed that the slower clearance of methamphetamine is likely to contribute to its previously reported longer-lasting stimulant effects relative to those of (-)-cocaine. High kidney uptake of d-methamphetamine or its labeled metabolites may account for the reported renal toxicity of d-methamphetamine in humans.
Figures





Similar articles
-
Fast uptake and long-lasting binding of methamphetamine in the human brain: comparison with cocaine.Neuroimage. 2008 Dec;43(4):756-63. doi: 10.1016/j.neuroimage.2008.07.020. Epub 2008 Jul 22. Neuroimage. 2008. PMID: 18708148 Free PMC article. Clinical Trial.
-
Maternal and fetal 11C-cocaine uptake and kinetics measured in vivo by combined PET and MRI in pregnant nonhuman primates.J Nucl Med. 2005 Feb;46(2):312-20. J Nucl Med. 2005. PMID: 15695792
-
Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain.Arch Gen Psychiatry. 1995 Jun;52(6):456-63. doi: 10.1001/archpsyc.1995.03950180042006. Arch Gen Psychiatry. 1995. PMID: 7771915
-
Cocaine addiction: hypothesis derived from imaging studies with PET.J Addict Dis. 1996;15(4):55-71. doi: 10.1300/J069v15n04_04. J Addict Dis. 1996. PMID: 8943582 Review.
-
[(11)]Cocaine: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancy.Nucl Med Biol. 2001 Jul;28(5):561-72. doi: 10.1016/s0969-8051(01)00211-6. Nucl Med Biol. 2001. PMID: 11516700 Review.
Cited by
-
CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice.Neuropharmacology. 2011 Oct-Nov;61(5-6):992-1000. doi: 10.1016/j.neuropharm.2011.06.028. Epub 2011 Jul 7. Neuropharmacology. 2011. PMID: 21762711 Free PMC article.
-
Vaccines against drug abuse.Clin Pharmacol Ther. 2012 Jan;91(1):60-70. doi: 10.1038/clpt.2011.281. Epub 2011 Nov 30. Clin Pharmacol Ther. 2012. PMID: 22130115 Free PMC article. Review.
-
Cocaine occupancy of sigma1 receptors and dopamine transporters in mice.Synapse. 2016 Mar;70(3):98-111. doi: 10.1002/syn.21877. Epub 2015 Dec 24. Synapse. 2016. PMID: 26618331 Free PMC article.
-
Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction.Ann N Y Acad Sci. 2008 Oct;1141:176-94. doi: 10.1196/annals.1441.023. Ann N Y Acad Sci. 2008. PMID: 18991958 Free PMC article. Review.
-
Neuroimaging and drug taking in primates.Psychopharmacology (Berl). 2011 Jul;216(2):153-71. doi: 10.1007/s00213-011-2222-7. Epub 2011 Mar 1. Psychopharmacology (Berl). 2011. PMID: 21360099 Free PMC article. Review.
References
-
- Volkow ND, Chang L, Wang G-J, et al. Association of dopamine transporter reduction with psychomotor impairment in MAMP abusers. Am J Psychiatry. 2001;158:377–382. - PubMed
-
- Fitzmaurice PS, Tong J, Yazdanpanah M, Liu PP, Kalasinsky KS, Kish SJ. Levels of 4-hydroxynonenal and malondialdehyde are increased in brain of human chronic users of MAMP. J Pharmacol Exp Ther. 2006;319:703–709. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical